Evidence map›Paper›PMID 40471233›Full record

ArticleChemPlusChem2025

Surface Deposition of Dome-Shaped Metal-Organic Complexes: A New Approach to the Generation of Single-Site Catalysts.

Küpra Yildiz, Kai Uwe Clausen, Christian Näther, Thomas Strunskus, Felix Tuczek

Abstract read
In one paragraph

Article in ChemPlusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Küpra YildizInstitute of Inorganic Chemistry, Christian-Albrechts-University of Kiel, Max-Eyth-Straße 2, 24118, Kiel, Germany.ORCID https://orcid.org/0009-0001-0007-9033
Kai Uwe ClausenInstitute of Inorganic Chemistry, Christian-Albrechts-University of Kiel, Max-Eyth-Straße 2, 24118, Kiel, Germany.ORCID https://orcid.org/0009-0001-9529-5803
Christian NätherInstitute of Inorganic Chemistry, Christian-Albrechts-University of Kiel, Max-Eyth-Straße 2, 24118, Kiel, Germany.ORCID https://orcid.org/0000-0001-8741-6508
Thomas StrunskusDepartment of Material Science, Christian-Albrechts-University of Kiel, Kaiserstraße 1, 24143, Kiel, Germany.ORCID https://orcid.org/0000-0003-3931-5635
Felix TuczekInstitute of Inorganic Chemistry, Christian-Albrechts-University of Kiel, Max-Eyth-Straße 2, 24118, Kiel, Germany.ORCID https://orcid.org/0000-0001-7290-9553

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel approach combining the advantages of heterogeneous with those of homogeneous catalysis is the deposition of metal-organic complexes on a metallic surface to create well-defined single-site catalysts. Dome-shaped organometallic complexes with weakly binding coligands are well suited for this purpose. With this in mind, a new dithia-[2.1.1]-(2,6)-pyridinophane ligand has been synthesized. The corresponding molybdenum(0) tricarbonyl complex is structurally and spectroscopically characterized in the bulk and in homogeneous solution. Monolayers of this complex are deposited on Au(111) and investigated with the help of surface spectroscopy (infrared reflection absorption spectroscopy, X-ray photoelectron spectroscopy, and near-edge X-ray absorption fine structure). These methods indicate a slightly tilted orientation of the complex on the gold surface, which is confirmed by density functional theory (DFT) calculations. The reactivity of the complex toward dioxygen is evaluated and compared to analogous complexes supported by aza- and thiacalix[3](2,6)pyridine ligands.

Indexed as

carbonyl ligandsgoldheterogeneous catalysismolybdenumsurface analysis

Identifiers

PMID40471233
PMCPMC12352724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.